Speaker Profile
Biography
Trever G. Bivona, MD, PhD, is Professor of Medicine and Cellular and Molecular Pharmacology at the University of California, San Francisco (UCSF), and a Senior Investigator at the Chan-Zuckerberg Biohub. A physician-scientist and thoracic oncologist, he leads research focused on understanding the molecular mechanisms driving cancer growth, evolution, and resistance to targeted therapies.
His laboratory focuses particularly on lung cancer, including EGFR-, ALK-, and RAS-driven tumors, using cancer genetics and functional genomics to identify vulnerabilities that may lead to more effective treatments. He directs the NCI-funded Bay Area Drug Resistance and Sensitivity Center, part of the Cancer Moonshot initiative.
Dr. Bivona earned his MD and PhD from New York University and completed clinical training at Brigham and Women's Hospital and Memorial Sloan Kettering Cancer Center. He is an elected member of the American Society for Clinical Investigation.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
